San Diego-based OncoSec Medical Inc. has appointed former Merck & Co. Inc. exec Robert H. Pierce as its chief medical officer.

Pierce was previously executive director of the department of pathology at Merck’s Palo Alto campus, leading a team of 20, OncoSec said.

OncoSec (OTC: ONCS), a $58 million market cap company, is developing a treatment for advanced-stage skin cancer.

-Meghana Keshavan